OC 43.2 Low-Dose Emicizumab Prophylaxis in Severe Hemophilia a Patients – A Pilot Study with a Much Anticipated Promise for a Resource Limited Country
| Autor: | Patil, R., S, C., Jijina, F. |
|---|---|
| Zdroj: | In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Plný text